Cargando…

Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran

AIM: Preeclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality. There is a genetic component in the development of PE with estimated heritability around 0.47. Several studies have investigated the association between maternal ABO blood groups (OMIM 110300) and risk of PE, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghasadeghi, Firoozeh, Saadat, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ID Design 2012/DOOEL Skopje 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420769/
https://www.ncbi.nlm.nih.gov/pubmed/28507623
http://dx.doi.org/10.3889/oamjms.2017.002
_version_ 1783234460711387136
author Aghasadeghi, Firoozeh
Saadat, Mostafa
author_facet Aghasadeghi, Firoozeh
Saadat, Mostafa
author_sort Aghasadeghi, Firoozeh
collection PubMed
description AIM: Preeclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality. There is a genetic component in the development of PE with estimated heritability around 0.47. Several studies have investigated the association between maternal ABO blood groups (OMIM 110300) and risk of PE, with contradictory results have emerged. Considering that there is no study in this filed from Iranian population, the present case-control study was carried out at Shiraz (south-west Iran). MATERIAL AND METHODS: In this study 331 women; 121 pregnant with PE and 210 normotensive pregnant women were included. Using blood group O (for ABO blood groups) or Rh+ (for Rh blood groups) as a reference, odds ratios (ORs) and its 95% confidence intervals (95% CI) of PE risk were estimated from logistic regression analysis. RESULTS: Although the A (OR = 0.67, 95% CI = 0.39-1.17, P = 0.165), B (OR = 0.86, 95% CI = 0.48-1.53, P = 0.615) and AB (OR = 1.14, 95% CI = 0.37-3.45, P = 0.812) phenotypes showed lower risks compared with the O blood group, statistical analysis indicated that there was no significant association between ABO phenotypes and risk of PE. The frequency of Rh- phenotype was higher among PE patients compared with the control group. However, the association was not significant (OR = 1.79, 95% CI = 0.69-4.65, P = 0.229). Adjusted ORs for age of participants and parity did not change the above-mentioned associations. CONCLUSION: Our present findings indicate that there is no association between ABO and Rh blood groups and risk of PE in Iranian population.
format Online
Article
Text
id pubmed-5420769
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher ID Design 2012/DOOEL Skopje
record_format MEDLINE/PubMed
spelling pubmed-54207692017-05-15 Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran Aghasadeghi, Firoozeh Saadat, Mostafa Open Access Maced J Med Sci Clinical Science AIM: Preeclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality. There is a genetic component in the development of PE with estimated heritability around 0.47. Several studies have investigated the association between maternal ABO blood groups (OMIM 110300) and risk of PE, with contradictory results have emerged. Considering that there is no study in this filed from Iranian population, the present case-control study was carried out at Shiraz (south-west Iran). MATERIAL AND METHODS: In this study 331 women; 121 pregnant with PE and 210 normotensive pregnant women were included. Using blood group O (for ABO blood groups) or Rh+ (for Rh blood groups) as a reference, odds ratios (ORs) and its 95% confidence intervals (95% CI) of PE risk were estimated from logistic regression analysis. RESULTS: Although the A (OR = 0.67, 95% CI = 0.39-1.17, P = 0.165), B (OR = 0.86, 95% CI = 0.48-1.53, P = 0.615) and AB (OR = 1.14, 95% CI = 0.37-3.45, P = 0.812) phenotypes showed lower risks compared with the O blood group, statistical analysis indicated that there was no significant association between ABO phenotypes and risk of PE. The frequency of Rh- phenotype was higher among PE patients compared with the control group. However, the association was not significant (OR = 1.79, 95% CI = 0.69-4.65, P = 0.229). Adjusted ORs for age of participants and parity did not change the above-mentioned associations. CONCLUSION: Our present findings indicate that there is no association between ABO and Rh blood groups and risk of PE in Iranian population. ID Design 2012/DOOEL Skopje 2017-01-14 /pmc/articles/PMC5420769/ /pubmed/28507623 http://dx.doi.org/10.3889/oamjms.2017.002 Text en Copyright: © 2017 Firoozeh Aghasadeghi, Mostafa Saadat. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
spellingShingle Clinical Science
Aghasadeghi, Firoozeh
Saadat, Mostafa
Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title_full Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title_fullStr Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title_full_unstemmed Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title_short Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
title_sort association between abo and rh blood groups and risk of preeclampsia: a case-control study from iran
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420769/
https://www.ncbi.nlm.nih.gov/pubmed/28507623
http://dx.doi.org/10.3889/oamjms.2017.002
work_keys_str_mv AT aghasadeghifiroozeh associationbetweenaboandrhbloodgroupsandriskofpreeclampsiaacasecontrolstudyfromiran
AT saadatmostafa associationbetweenaboandrhbloodgroupsandriskofpreeclampsiaacasecontrolstudyfromiran